The T allele of the interferon-gamma +874A/T polymorphism is associated with bipolar disorder

References

• Yang K, Xie G, Zhang Z, Wang C, Li W, Zhou W, . Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust N Z J Psychiatry 2007;41:266–73.
   PubMed Web of Science ®Google Scholar
• Kim Y-K, Na K-S, Shin K-H, Jung H-Y, Choi S-H, Kim J-B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1044–53.
   PubMed Web of Science ®Google Scholar
• Kronfol Z, Hamdan-Allen G, Black DW. Fever and leukocytosis: Physical manifestations of bipolar affective disorder? Prog Neuropsychopharmacol Biol Psychiatry 1988;12:887–91.
   PubMed Web of Science ®Google Scholar
• Lazarus JH, McGregor AM, Ludgate M, Darke C, Creagh FM, Kingswood CJ. Effect of lithium carbonate therapy on thyroid immune status in manic depressive patients: A prospective study. J Affect Disord 1986;11:155–60.
   PubMed Web of Science ®Google Scholar
• Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749–95.
   PubMed Web of Science ®Google Scholar
• Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999;26:1–3.
   PubMedGoogle Scholar
• Yamada H, Mizuno S, Reza-Gholizadeh M, Sugawara I. Relative importance of NF-kappaB p50 in mycobacterial infection. Infect Immun 2001;69:7100–5.
   PubMed Web of Science ®Google Scholar
• Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61:863–6.
   PubMed Web of Science ®Google Scholar
• Rossouw M, Nel H, Cooke G, van Helden P, Hoal E. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003;361:1871–2.
   PubMed Web of Science ®Google Scholar
• Kim YK, Myint AM, Lee BH, Han CS, Lee SW, Leonard B, . T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatry Res 2004;129:267–72.
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 1978;133:429–35.
   PubMed Web of Science ®Google Scholar
• Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799–812.
   Web of Science ®Google Scholar
• Bai J, Lin M, Zeng X, Zhang Y, Wang Z, Shen J, . Association of polymorphisms in the human IFN-gamma and IL-4 gene with oral lichen planus: A study in an ethnic Chinese cohort. J Interferon Cytokine Res 2008;28:351–8.
   PubMed Web of Science ®Google Scholar
• Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y. Association between the severity of Hashimoto's disease and the functional + 874A/T polymorphism in the interferon-gamma gene. Endocr J 2006;53:473–8.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu J, Chen Z, Zhou Z, Feng X, Zhou Y, . Interferon-gamma +874A/T and interleukin-4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura. Eur J Haematol 2007;79:191–7.
   PubMed Web of Science ®Google Scholar
• Lio D, Scola L, Crivello A, Bonaf M, Franceschi C, Olivieri F, . Allele frequencies of + 74T- > A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 2002;37:315–9.
   PubMed Web of Science ®Google Scholar
• Poli F, Nocco A, Berra S, Scalamogna M, Taioli E, Longhi E, . Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet 2002;29:237–40.
   PubMedGoogle Scholar
• Su KP, Leu SJ, Yang YY, Shen W, Chou YM, Tsai SY. Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission. J Affect Disord 2002;71:205–9.
   PubMed Web of Science ®Google Scholar
• Liu HC, Yang YY, Chou YM, Chen KP, Shen W, Leu SJ. Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol 2004;150:116–22.
   PubMed Web of Science ®Google Scholar
• Clerici M, Arosio B, Mundo E, Cattaneo E, Pozzoli S, Dell'osso B, . Cytokine polymorphisms in the pathophysiology of mood disorders. CNS spectrums 2009;14:419–25.
   PubMed Web of Science ®Google Scholar
• Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 2007;104:91–5.
   PubMed Web of Science ®Google Scholar
• O'Brien S, Scully P, Scott L, Dinan T. Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients. J Affect Disord 2006;90:263–7.
   PubMed Web of Science ®Google Scholar
• Balakumar P, Singh M. Anti-tumour necrosis factor-alpha therapy in heart failure: Future directions. Basic Clin Pharmacol Toxicol 2006;99:391–7.
   PubMed Web of Science ®Google Scholar
• Kronfol Z, Remick DG. Cytokines and the brain: Implications for clinical psychiatry. Am J Psychiatry 2000;157:683–94.
   PubMed Web of Science ®Google Scholar
• Bhardwaj A, Aggarwal B. Receptor-mediated choreography of life and death. J Clin Immunol 2003;23:317–32.
   PubMedGoogle Scholar
• Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983;158:670–89.
   PubMed Web of Science ®Google Scholar
• Halliwell B. The biological effects of the superoxide radical and its products. Bull Eur Physiopathol Respir 1981;17 Suppl:21–9.
   PubMedGoogle Scholar
• Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, . Functional outcome in bipolar disorder: The role of clinical and cognitive factors. Bipolar Dis 2007;9:103–13.
   PubMed Web of Science ®Google Scholar
• Soares J, Kochunov P, Monkul ES, Nicoletti M, Brambilla P, Sassi R, . Structural brain changes in bipolar disorder using deformation field morphometry. Neuroreport 2005;16:541–4.
   PubMed Web of Science ®Google Scholar
• Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie S, Johnstone EC, . Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007;62:894–900.
   PubMed Web of Science ®Google Scholar
• Blumberg H, Krystal J, Bansal R, Martin A, Dziura J, Durkin K, . Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: A cross-sectional study. Biol Psychiatry 2006;59:611–8.
   PubMed Web of Science ®Google Scholar
• Schmitt E, Hoehn P, Huels C, Goedert S, Palm N, Rde E, . T helper type 1 development of naive CD4 + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur J Immunol 1994;24:793–8.
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000;14:23–42.
   PubMed Web of Science ®Google Scholar
• Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR, . Transforming growth factor-beta in leishmanial infection: A parasite escape mechanism. Science 1992;257:545–8.
   PubMed Web of Science ®Google Scholar
• Letterio JJ, Roberts AB. TGF-beta: A critical modulator of immune cell function. Clin Immunol Immunopathol 1997;84:244–50.
   PubMedGoogle Scholar
• Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, . Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:61–4.
   PubMedGoogle Scholar